Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia
- PMID: 23591716
- DOI: 10.1007/s12185-013-1328-6
Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia
Abstract
The purpose of this study was to investigate the long-term effects of laparoscopic splenectomy (LS) for patients with chronic immune thrombocytopenia (ITP), and to identify predictive factors for promising hematological outcomes. We retrospectively analyzed the clinical records and follow-up data in patients who underwent LS for chronic ITP from November 2005 to August 2012. The related parameters were assessed by univariate and multivariate logistic regression analyses. The curve of life table was drawn to clarify the long-term response rate. Of the 92 included patients, 49 (53.3 %) patients achieved a complete response, 21 patients (22.8 %) a partial response, and the remaining 22 (23.9 %) showed no response to LS. Eleven patients relapsed within 1 year after LS, especially within 3 months (n = 7), while three patients relapsed 17, 26, and 28 months after LS, respectively. Long-term specific complications after LS were not observed. Platelet counts on postoperative month 3 (POM 3) is a significant independent predictor of long-term favorable hematological outcomes (P < 0.001). Based on our study, we conclude that LS is associated with promising long-term response for patients with chronic ITP, and platelet counts on POM 3 could be used as a predictor of long-term hematological outcome.
Similar articles
-
Platelet count on preoperative day 1 predicts the long-term responses to laparoscopic splenectomy for Chinese patients with medically refractory idiopathic thrombocytopenic purpura.BMC Surg. 2018 Nov 26;18(1):108. doi: 10.1186/s12893-018-0446-8. BMC Surg. 2018. PMID: 30477462 Free PMC article.
-
Laparoscopic splenectomy for immune thrombocytopenic purpura at a teaching institution.Chin Med J (Engl). 2011 Apr;124(8):1175-80. Chin Med J (Engl). 2011. PMID: 21542991
-
Prognostic Factors for Immune Thrombocytopenic Purpura Remission after Laparoscopic Splenectomy: A Cohort Study.Medicina (Kaunas). 2019 Apr 18;55(4):112. doi: 10.3390/medicina55040112. Medicina (Kaunas). 2019. PMID: 31003557 Free PMC article.
-
Efficacy and safety of laparoscopic splenectomy: review of 14 adult cases using the lateral approach.Bol Asoc Med P R. 2009 Apr-Jun;101(2):43-9. Bol Asoc Med P R. 2009. PMID: 19954101 Review.
-
[Laparoscopic and open splenectomy for idiopathic thrombocytopenic purpura].Nihon Rinsho. 2003 Apr;61(4):599-603. Nihon Rinsho. 2003. PMID: 12718082 Review. Japanese.
Cited by
-
Predictive Factors for Success of Laparoscopic Splenectomy for ITP.JSLS. 2018 Oct-Dec;22(4):e2018.00021. doi: 10.4293/JSLS.2018.00021. JSLS. 2018. PMID: 30524182 Free PMC article.
-
Platelet count evolution as a predictor of outcome after splenectomy for immune thrombocytopenic purpura.Int J Hematol. 2017 Apr;105(4):433-439. doi: 10.1007/s12185-016-2121-0. Epub 2016 Oct 27. Int J Hematol. 2017. PMID: 27787747
-
Platelet count on preoperative day 1 predicts the long-term responses to laparoscopic splenectomy for Chinese patients with medically refractory idiopathic thrombocytopenic purpura.BMC Surg. 2018 Nov 26;18(1):108. doi: 10.1186/s12893-018-0446-8. BMC Surg. 2018. PMID: 30477462 Free PMC article.
-
Laparoscopic splenectomy for immune thrombocytopenia (ITP): long-term outcomes of a modern cohort.Surg Endosc. 2019 Feb;33(2):475-485. doi: 10.1007/s00464-018-6321-y. Epub 2018 Jul 9. Surg Endosc. 2019. PMID: 29987573
-
Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.BMC Health Serv Res. 2015 Jan 22;15:2. doi: 10.1186/s12913-015-0681-y. BMC Health Serv Res. 2015. PMID: 25609557 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources